MX260260B - Formulaciones semi-solidas para la administracion oral de taxoides. - Google Patents

Formulaciones semi-solidas para la administracion oral de taxoides.

Info

Publication number
MX260260B
MX260260B MXPA06000636A MX260260B MX 260260 B MX260260 B MX 260260B MX PA06000636 A MXPA06000636 A MX PA06000636A MX 260260 B MX260260 B MX 260260B
Authority
MX
Mexico
Prior art keywords
taxoids
semi
oral administration
solid formulations
formulations
Prior art date
Application number
Other languages
English (en)
Inventor
Carole Neves
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MXPA06000636A publication Critical patent/MXPA06000636A/es
Publication of MX260260B publication Critical patent/MX260260B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA06000636 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides. MX260260B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291795A EP1498120A1 (en) 2003-07-18 2003-07-18 Semi-solid formulations for the oral administration of taxoids
PCT/EP2004/008551 WO2005013968A1 (en) 2003-07-18 2004-07-15 Semi-solid formulations for the oral administration of taxoids

Publications (2)

Publication Number Publication Date
MXPA06000636A MXPA06000636A (es) 2006-04-19
MX260260B true MX260260B (es) 2008-09-04

Family

ID=33462258

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000636 MX260260B (es) 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides.

Country Status (21)

Country Link
US (1) US20050070496A1 (es)
EP (2) EP1498120A1 (es)
JP (1) JP5116306B2 (es)
KR (1) KR101143341B1 (es)
CN (1) CN1826110B (es)
AR (1) AR045996A1 (es)
AT (1) ATE388701T1 (es)
AU (1) AU2004262496B2 (es)
BR (1) BRPI0412759A (es)
CA (1) CA2532667A1 (es)
DE (1) DE602004012413T2 (es)
DK (1) DK1648440T3 (es)
ES (1) ES2303642T3 (es)
HK (1) HK1091743A1 (es)
IL (1) IL173110A (es)
IN (1) IN229997B (es)
MX (1) MX260260B (es)
MY (1) MY137965A (es)
PT (1) PT1648440E (es)
TW (1) TWI342774B (es)
WO (1) WO2005013968A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
CA2652926A1 (en) * 2006-05-26 2007-12-06 Bayer Healthcare Llc Drug combinations with substituted diaryl ureas for the treatment of cancer
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
FR2924024B1 (fr) 2007-11-27 2012-08-17 Centre Nat Rech Scient Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
FR2931152B1 (fr) * 2008-05-16 2010-07-30 Centre Nat Rech Scient Nouveau systeme de transfert d'acide nucleique
MY164086A (en) 2009-10-29 2017-11-30 Aventis Pharma Sa Novel antitumoral use of cabazitaxel
WO2011139899A2 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103980232A (zh) * 2014-06-05 2014-08-13 北京诺普德医药科技有限公司 10-乙酰基多西紫杉醇及其用途
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
CN113698369A (zh) * 2021-08-31 2021-11-26 无锡紫杉药业有限公司 一种除去卡巴他赛中特定单杂的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5478854A (en) * 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
CN100341485C (zh) * 1998-04-01 2007-10-10 斯凯伊药品加拿大公司 抗癌组合物
JP2003500368A (ja) * 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス，インコーポレイテッド 溶解度が不十分な薬剤のためのエマルジョンビヒクル
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
EP1365759A2 (en) * 2001-01-18 2003-12-03 PHARMACIA & UPJOHN COMPANY Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2003045357A1 (en) * 2001-11-27 2003-06-05 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
WO2003053350A2 (en) * 2001-12-20 2003-07-03 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
JP2005523295A (ja) * 2002-03-01 2005-08-04 ノバガリ、ファルマ、エスアー 難溶性薬剤の自己乳化型薬物送達システム
KR20090072980A (ko) * 2007-12-28 2009-07-02 서울옵토디바이스주식회사 발광 다이오드 및 그 제조방법

Also Published As

Publication number Publication date
IL173110A (en) 2011-04-28
MY137965A (en) 2009-04-30
US20050070496A1 (en) 2005-03-31
DK1648440T3 (da) 2008-07-14
IN2006CH00198A (es) 2007-06-08
JP2009513558A (ja) 2009-04-02
AU2004262496A1 (en) 2005-02-17
EP1648440B1 (en) 2008-03-12
EP1498120A1 (en) 2005-01-19
CN1826110A (zh) 2006-08-30
MXPA06000636A (es) 2006-04-19
AR045996A1 (es) 2005-11-23
PT1648440E (pt) 2008-06-24
DE602004012413T2 (de) 2009-03-12
CN1826110B (zh) 2010-05-12
AU2004262496B2 (en) 2009-02-05
HK1091743A1 (en) 2007-01-26
JP5116306B2 (ja) 2013-01-09
ATE388701T1 (de) 2008-03-15
KR20060037370A (ko) 2006-05-03
ES2303642T3 (es) 2008-08-16
KR101143341B1 (ko) 2012-05-24
TWI342774B (en) 2011-06-01
WO2005013968A1 (en) 2005-02-17
CA2532667A1 (en) 2005-02-17
DE602004012413D1 (de) 2008-04-24
BRPI0412759A (pt) 2006-09-26
IL173110A0 (en) 2006-06-11
EP1648440A1 (en) 2006-04-26
IN229997B (es) 2009-03-27
TW200517104A (en) 2005-06-01

Similar Documents

Publication Publication Date Title
HK1091743A1 (en) Semi-solid formulations for the oral administration of taxoids
EP1622540A4 (en) FORMULATIONS FOR CELL-PLAN-DEPENDENT CANCER
ZA200606174B (en) Multiparticulate formulations for oral delivery
IL173571A0 (en) Injectable, oral, or topical sustained release pharmaceutical formulations
IL172824A0 (en) Pharmaceutical formulations
GB0302671D0 (en) Pharmaceutical formulations
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
GB0210397D0 (en) Pharmaceutical formulations
HK1087399A1 (en) Pharmaceutical formulations comprising highly purebases of 3, 3-giphenylpropylamine monoesters
HK1089951A1 (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
GB0302672D0 (en) Pharmaceutical formulations
SI1592457T1 (sl) Konjugat folat-vinblastin kot zdravilo
WO2004087101A3 (en) Oral formulations of cladribine
HK1092715A1 (en) Melt-formulated, multi-particulate oral dosage form
IL173111A0 (en) Semi-solid formulations containing azetidine derivatives
GB0316341D0 (en) Pharmaceutical formulations
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
EP1361866A4 (en) EMULSIONS AS SOLID DOSAGE FORMS FOR ORAL ADMINISTRATION
ZA200204905B (en) Improved pharmaceutical dental formulations.
ITRM20020357A0 (it) Composizione liquida per la somministrazione orale di lorazepam.
ZA200803553B (en) Oral formulations comprising 3'-azidonucleosides
GB0316335D0 (en) Pharmaceutical formulations
HU0401927D0 (en) New oral taxane formulations
GB0326642D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
FG Grant or registration